Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1978 1
1981 2
1982 1
1983 2
1984 1
1985 4
1986 4
1987 7
1988 1
1989 1
1991 1
1993 2
1994 2
1996 1
1998 1
1999 1
2000 2
2001 2
2003 1
2004 1
2005 1
2009 1
2010 1
2013 1
2015 1
2016 3
2017 3
2018 2
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Li C, Romero-Masters JC, Huebner S, Ohashi M, Hayes M, Bristol JA, Nelson SE, Eichelberg MR, Van Sciver N, Ranheim EA, Scott RS, Johannsen EC, Kenney SC. Li C, et al. Among authors: bristol ja. PLoS Pathog. 2020 Jun 15;16(6):e1008590. doi: 10.1371/journal.ppat.1008590. eCollection 2020 Jun. PLoS Pathog. 2020. PMID: 32542010 Free PMC article.
An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Zumwalde NA, Bristol JA, Nelson SE, Ma S, Ranheim EA, Gumperz JE, Johannsen EC, Kenney SC. Romero-Masters JC, et al. Among authors: bristol ja. J Virol. 2020 May 4;94(10):e02168-19. doi: 10.1128/JVI.02168-19. Print 2020 May 4. J Virol. 2020. PMID: 32132242 Free PMC article.
New positive inotropic agents.
Jafri SM, Bristol JA. Jafri SM, et al. Among authors: bristol ja. Henry Ford Hosp Med J. 1986;34(3):188-92. Henry Ford Hosp Med J. 1986. PMID: 3542907 Free article. Review. No abstract available.
B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
Romero-Masters JC, Huebner SM, Ohashi M, Bristol JA, Benner BE, Barlow EA, Turk GL, Nelson SE, Baiu DC, Van Sciver N, Ranheim EA, Gumperz J, Sherer NM, Farrell PJ, Johannsen EC, Kenney SC. Romero-Masters JC, et al. Among authors: bristol ja. PLoS Pathog. 2020 Feb 14;16(2):e1008365. doi: 10.1371/journal.ppat.1008365. eCollection 2020 Feb. PLoS Pathog. 2020. PMID: 32059024 Free PMC article.
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.
Bristol JA, Djavadian R, Albright ER, Coleman CB, Ohashi M, Hayes M, Romero-Masters JC, Barlow EA, Farrell PJ, Rochford R, Kalejta RF, Johannsen EC, Kenney SC. Bristol JA, et al. PLoS Pathog. 2018 Jul 27;14(7):e1007179. doi: 10.1371/journal.ppat.1007179. eCollection 2018 Jul. PLoS Pathog. 2018. PMID: 30052684 Free PMC article.
Analogs of camptothecin.
Horwitz SB, Bristol JA, Comins DL, Davenport RW, Kane MJ, Lyle RE, Maloney JR, Portlock DE. Horwitz SB, et al. Among authors: bristol ja. J Med Chem. 1975 May;18(5):535-7. doi: 10.1021/jm00239a024. J Med Chem. 1975. PMID: 1171240
An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Bristol JA, Ma S, Ranheim EA, Gumperz J, Johannsen EC, Kenney SC. Romero-Masters JC, et al. Among authors: bristol ja. PLoS Pathog. 2018 Aug 20;14(8):e1007221. doi: 10.1371/journal.ppat.1007221. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30125329 Free PMC article.
55 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page